Tetra Bio Pharma - CEO and CRO, Dr. Guy Chamberland.
CEO and CRO, Dr. Guy Chamberland.
Source: Tetra Bio-Pharma.
  • Tetra Bio-Pharma (TBP) will receive up to C$150,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)
  • The award follows $4.5 million from the Government of Quebec
  • The funds will support development programs for Tetra’s ARDS-003 formulation
  • ARDS-003 is intended to modulate acute systemic inflammation and prevent sepsis, organ damage, and acute respiratory distress syndrome
  • Tetra Bio-Pharma specializes in cannabinoid-derived drug discovery and development
  • Tetra Bio-Pharma (TBP) opened with a gain of 25 per cent, trading at $0.025 per share

Tetra Bio-Pharma (TBP) will receive up to C$150,000 in funding from the NRC IRAP.

The funds will support a research and development project for its ARDS-003 oral formulation, including formulation optimization and animal non-GLP pharmacokinetic studies.

The award follows $4.5 million from the Government of Quebec for the clinical development of ARDS-003 to treat acute respiratory distress syndrome (ARDS).

ARDS-003 is the First in-Human drug product containing Onternabez, a full agonist of the type 2 cannabinoid receptor. ARDS-003 is intended to modulate acute systemic inflammation and prevent sepsis, ARDS, and organ damage. Tetra’s ARDS-based pre-clinical studies demonstrated that its formulation slows disease progression.

“We are grateful to receive this funding, which will support the development of the ARDS-003 oral program by investigating safety, pharmacokinetics, and pharmacodynamics,” stated Dr. Guy Chamberland, Tetra’s CEO and Chief Regulatory Officer.

Tetra Bio-Pharma specializes in cannabinoid-derived drug discovery and development. Its product pipeline currently seeks to address pain, inflammation and oncology.

Tetra Bio-Pharma (TBP) opened with a gain of 25 per cent, trading at $0.025 per share.


More From The Market Online

Buzz on the Bullboards: The challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grappled with a host of challenges, from surging inflation data to escalating tensions in the Middle East

@ the Bell: TSX sees first positive day in a week

Canadian stock markets moved up on Wednesday as investors await fresh cues about timing of this year’s interest rate cuts
TC Energy - Shot from the NGTL pipeline system.

TC Energy’s latest fuel spill sparks wildfire

The NGTL natural gas pipeline, owned by TC Energy, ruptured and caused a wildfire 40 kilometres northwest of Edson, Alberta, Tuesday morning.
PyroGenesis - PyroGenesis' STP torch for refrigerant destruction, hydrocracking and heating.

PyroGenesis to help global mining leader lower emissions

PyroGenesis Canada (TSX:PYR) signs a contract with a global mining supplier to apply its electric plasma torches towards emissions reduction.